177Lu-JH12
/ Bivision Biomedical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
Preclinical evaluation and clinical translation of 68Ga/177Lu-JH12, a novel CXCR4-targeting radioligand
(AACR 2025)
- "JH12 appears to perform better in tumor visualization and retention, which might be a promising biological radio-tracer in CXCR4-targeting imaging and treatment."
Preclinical • Oncology • CXCR4
1 to 1
Of
1
Go to page
1